Tumor Necrosis Factor Receptor Superfamily Member 4 - Pipeline Review, H2 2018 Market Report; Launched via MarketResearchReports.com
Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) pipeline Target constitutes close to 23 molecules. Out of which approximately 22 molecules are developed by companies and remaining by the universities/institutes.
View full press release